ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

ClinicalTrials.gov ID: NCT00911170

Public ClinicalTrials.gov record NCT00911170. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Pegfilgrastim Admininstered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab & Either 5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX) or 5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)

Study identification

NCT ID
NCT00911170
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
847 participants

Conditions and interventions

Interventions

  • Bevacizumab Biological
  • Pegfilgrastim Drug
  • Placebo Drug
  • Standard Chemotherapy Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2, 2009
Primary completion
Sep 16, 2012
Completion
Jan 1, 2015
Last update posted
Dec 28, 2017

2009 – 2015

United States locations

U.S. sites
72
U.S. states
30
U.S. cities
69
Facility City State ZIP Site status
Research Site Muscle Shoals Alabama 35661
Research Site Jonesboro Arkansas 72401
Research Site Anaheim California 92801
Research Site Beverly Hills California 90211
Research Site Modesto California 95355
Research Site San Diego California 92161
Research Site Greenwich Connecticut 06830
Research Site Dover Delaware 19901
Research Site Gainesville Florida 32605
Research Site Loxahatchee Groves Florida 33470
Research Site Port Saint Lucie Florida 34952
Research Site Tamarac Florida 33321
Research Site Honolulu Hawaii 96813
Research Site Gurnee Illinois 60031
Research Site Maywood Illinois 60153
Research Site Quincy Illinois 62301
Research Site Rockford Illinois 61108
Research Site New Albany Indiana 47150
Research Site South Bend Indiana 46617
Research Site Council Bluffs Iowa 51503
Research Site Sioux City Iowa 51101
Research Site Waterloo Iowa 50701
Research Site Waterloo Iowa 50702
Research Site Hutchinson Kansas 67502
Research Site Hazard Kentucky 41701
Research Site Lexington Kentucky 40503
Research Site Paducah Kentucky 42001
Research Site Shreveport Louisiana 71103
Research Site Bethesda Maryland 20817
Research Site Cumberland Maryland 21502
Research Site Randallstown Maryland 21133
Research Site Towson Maryland 21204
Research Site Boston Massachusetts 02130
Research Site Boston Massachusetts 02135
Research Site Jefferson City Missouri 65109
Research Site Kansas City Missouri 64118
Research Site Springfield Missouri 65807
Research Site St Louis Missouri 63136
Research Site Billings Montana 59101
Research Site Grand Island Nebraska 68803
Research Site Kearney Nebraska 68845
Research Site Omaha Nebraska 68131
Research Site Portsmouth New Hampshire 03801
Research Site Little Silver New Jersey 07739
Research Site Somerville New Jersey 08876
Research Site Albuquerque New Mexico 87131
Research Site Lake Success New York 11042
Research Site Nyack New York 10960
Research Site Asheville North Carolina 28801
Research Site Hickory North Carolina 28602
Research Site High Point North Carolina 27262
Research Site Winston-Salem North Carolina 27103
Research Site Canton Ohio 44708
Research Site Cincinnati Ohio 45219
Research Site Massillon Ohio 44646
Research Site Middletown Ohio 45042
Research Site Lancaster Pennsylvania 17605
Research Site Langhorne Pennsylvania 19047
Research Site Reading Pennsylvania 19605
Research Site Upland Pennsylvania 19013
Research Site West Reading Pennsylvania 19611
Research Site Willow Grove Pennsylvania 19090
Research Site Hilton Head Island South Carolina 29926
Research Site Myrtle Beach South Carolina 29572
Research Site Nashville Tennessee 37203
Research Site Bryan Texas 77802
Research Site Corpus Christi Texas 78405
Research Site Corpus Christi Texas 78412
Research Site Abingdon Virginia 24211
Research Site Lynchburg Virginia 24501
Research Site Kennewick Washington 99336
Research Site Spokane Washington 99220

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 82 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00911170, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 28, 2017 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00911170 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →